The Global Meningococcal Initiative has reported today that, whilst incidence of meningococcal disease in the Asia-Pacific region appears to be low, it is likely to affect many more people in the region than existing data suggests.

Preliminary data from the UK’s national meningitis B immunisation programme has shown that Bexsero, the vaccine introduced to combat meningitis B, has been 83% effective against all MenB strains in infants and 94% against vaccine preventable strains for all children receiving the first two of three recommended doses.